Basic Information
| LncRNA/CircRNA Name | FRlnc1 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | gastric cancer |
| ICD-0-3 | C16 |
| Methods | qPCR |
| Sample | gastric cancer tissues |
| Expression Pattern | up-regulated |
| Function Description | Increased FRLnc1 expression was associated with depth of tumor,differentiation degree,distant metastasis, TNM stage and lymph node metastasis.FRLnc1 expression was an independent prognostic marker for survival in patients with GC.overall patient survival for those with low FRLnc1 expression was significantly longer than those patients with high FRLnc1 expression. |
| Pubmed ID | 29424899 |
| Year | 2018 |
| Title | Clinical prognostic value of A FOXM1 related long non-coding RNA expression in gastric cancer. |
External Links
| Links for FRlnc1 | GenBank HGNC NONCODE |
| Links for gastric cancer | OMIM COSMIC |